Biotechs post record November gains as outlook improves
Maria Vonotna November was a memorable month for biotech stocks, as gene therapy developers outperformed and pharmaceutical giants looked for ...
Maria Vonotna November was a memorable month for biotech stocks, as gene therapy developers outperformed and pharmaceutical giants looked for ...